Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Sodium Shaboli BP EP USP Pharma Grade carries an important role in many pharmaceutical and industrial processes. Walk into any lab where credible medicine is made, and chances are this compound sits somewhere in storage. Known for its clear white appearance, you usually find it in solid forms — distinctly as flakes, powder, or even large crystals. Its formula, often designated as NaC7H4SO3, links sodium ions to a benzoic acid structure. This gives it a certain strength in reactivity and stability, making it a common building block for pharma and chemical synthesis.
You can run a hand through a sample of Sodium Shaboli and get a gritty texture from the flakes, or view crystalline powder that clumps under humidity. As a solid, it resists moisture better than some salts, but open-air conditions eventually cause it to cake. Its density measures close to 1.6 g/cm³, which compares to many staple sodium salts but feels noticeably heavier if you weigh out similar volumes in the lab. The melting point passes 300°C, holding strong as a non-volatile, robust raw material, especially under the heat of chemical synthesis. The color never strays from bright white, unless impurity sneaks into an unsealed drum. In water, Sodium Shaboli dissolves fast, but it won’t cloud the solution; the liquid stays clear, helping technicians confirm both purity and safety in pharmaceutical runs.
This compound’s molecular formula, NaC7H4SO3, reveals the backbone behind its action. You get a sodium atom linked with a sulfonate group on a benzoic base — a setup that lets the compound blend chemical reactivity with stability. Under a microscope or through X-ray crystallography, this structure confirms itself in the highly ordered crystals formed at room temperature. The weight tallies at around 174.16 g/mol, making calculations easier for dose and concentration in larger mix tanks or when scaling up for manufacturing. Every lab run comes back to this structure, giving reassurance in the repeatability of processes that rely on high quality and consistent output.
People working in regulated environments often check for compliance with British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP) standards. Sodium Shaboli arrives with the necessary paperwork, tying it to HS Code 291512, which flags it for customs tracking and economic statistics. Specification sheets list purity above 99%, low moisture, and almost no heavy metal residues. You don’t get the luxury of loose tolerance, especially when this compound enters the bloodstream through pharmaceuticals. Its clear, transparent solution at 10% in water stands as a minimum pass, with pH measurements always within the safe, neutral range.
The journey of Sodium Shaboli begins at raw material suppliers, but the story doesn’t end there. Pharmaceutical companies pull from vetted batches, trusting that every lot matches the molecular fingerprint and meets all pharmacopoeial standards. Its solubility and chemical consistency make it valuable for chemical synthesis of APIs, excipients, and intermediates. It plays well with a host of other materials, forming reliable bonds and resisting unwanted side reactions. No reckless substitutions—every gram counts, because finished medicine depends on each raw ingredient showing up for work just as described.
People tend to underestimate the risks with substances that look as harmless as table salt. Sodium Shaboli does not demand extreme caution on every front, but regulations still treat it as potentially harmful if taken in large quantities or handled carelessly. Contact with skin might cause mild irritation for sensitive individuals; dust in the eyes always brings discomfort. The safety data sheet gives a straightforward account: use gloves, avoid inhaling powder, store away from acids, and always seal containers when not in use. Disposal rules align with other inert salts but always follow local ordinances that oversee pharmaceuticals.
The trick to working with Sodium Shaboli in pharma has never been about finding the cheapest bag, but about consistent sourcing and trustworthy analysis. Bad actors in the supply chain can introduce contaminants, so every credible manufacturer expects certificates of analysis matching each batch. These checks go beyond routine; labs run spot tests, compare densitometry results, and double-check purity under varying conditions. Patients and professionals alike rely on transparent documentation, so audit trails travel with every shipment. The move toward even tighter quality controls makes sense. Drug makers cannot afford slip-ups, and substitutions or mistakes in molecular structure can ruin entire production runs or, worse, harm patients.
While Sodium Shaboli shows strong reliability, areas for betterment usually appear in sourcing and transparency. Traceability tools—like digital batch tracking, QR-coded lot numbers, and open access to testing results—could set new standards. Further automation in production might minimize hands-on transfer of the material, leading to even tighter control of contamination. Ongoing collaboration between chemical suppliers, regulators, and pharma firms stands as the way forward; open data, regular audits, and fast recall procedures save time, money, and lives. Cleaner and safer handling means fewer headaches for everyone in the supply chain, especially those responsible for the final product in a patient’s hands.
Chengguan District, Lanzhou, Gansu, China
